In glioblastoma, BDNF-AS plays a tumor-suppressor role by inducing the degradation of RAX2 and stabilizing TP53 transcripts to inhibit proliferation, migration, and invasiveness of malignant cells [56,57]. Here, TP53 is linked to neoplasm.